139 related articles for article (PubMed ID: 18855683)
1. Protein kinase inhibitors in the treatment of pulmonary fibrosis.
Garneau-Tsodikova S; Thannickal VJ
Curr Med Chem; 2008; 15(25):2632-40. PubMed ID: 18855683
[TBL] [Abstract][Full Text] [Related]
2. Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.
Vittal R; Horowitz JC; Moore BB; Zhang H; Martinez FJ; Toews GB; Standiford TJ; Thannickal VJ
Am J Pathol; 2005 Feb; 166(2):367-75. PubMed ID: 15681821
[TBL] [Abstract][Full Text] [Related]
3. Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.
Zhao XK; Cheng Y; Liang Cheng M; Yu L; Mu M; Li H; Liu Y; Zhang B; Yao Y; Guo H; Wang R; Zhang Q
Sci Rep; 2016 Jan; 6():19276. PubMed ID: 26763945
[TBL] [Abstract][Full Text] [Related]
4. Targeting focal adhesion kinase in fibrotic diseases.
Lagares D; Kapoor M
BioDrugs; 2013 Feb; 27(1):15-23. PubMed ID: 23329396
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.
Lagares D; Busnadiego O; García-Fernández RA; Kapoor M; Liu S; Carter DE; Abraham D; Shi-Wen X; Carreira P; Fontaine BA; Shea BS; Tager AM; Leask A; Lamas S; Rodríguez-Pascual F
Arthritis Rheum; 2012 May; 64(5):1653-64. PubMed ID: 22492165
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.
Horowitz JC; Rogers DS; Sharma V; Vittal R; White ES; Cui Z; Thannickal VJ
Cell Signal; 2007 Apr; 19(4):761-71. PubMed ID: 17113264
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
[TBL] [Abstract][Full Text] [Related]
10. PI3K/Akt signaling is involved in the pathogenesis of bleomycin‑induced pulmonary fibrosis via regulation of epithelial‑mesenchymal transition.
Zhang XL; Xing RG; Chen L; Liu CR; Miao ZG
Mol Med Rep; 2016 Dec; 14(6):5699-5706. PubMed ID: 27878273
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral gene transfer of endothelin-1 in the lung induces pulmonary fibrosis through the activation of focal adhesion kinase.
Lagares D; Busnadiego O; García-Fernández RA; Lamas S; Rodríguez-Pascual F
Am J Respir Cell Mol Biol; 2012 Dec; 47(6):834-42. PubMed ID: 22962065
[TBL] [Abstract][Full Text] [Related]
13. Lung epithelial cell focal adhesion kinase signaling inhibits lung injury and fibrosis.
Wheaton AK; Agarwal M; Jia S; Kim KK
Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L722-L730. PubMed ID: 28283477
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.
Lawrence J; Nho R
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518028
[TBL] [Abstract][Full Text] [Related]
15. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal.
Wynes MW; Frankel SK; Riches DW
J Leukoc Biol; 2004 Nov; 76(5):1019-27. PubMed ID: 15316031
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.
Horowitz JC; Ajayi IO; Kulasekaran P; Rogers DS; White JB; Townsend SK; White ES; Nho RS; Higgins PD; Huang SK; Sisson TH
Int J Biochem Cell Biol; 2012 Jan; 44(1):158-69. PubMed ID: 22041029
[TBL] [Abstract][Full Text] [Related]
17. The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.
Abdalla M; Sabbineni H; Prakash R; Ergul A; Fagan SC; Somanath PR
Br J Pharmacol; 2015 Aug; 172(16):4173-88. PubMed ID: 26033700
[TBL] [Abstract][Full Text] [Related]
18. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
Uhal BD; Kim JK; Li X; Molina-Molina M
Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
